Here's Why Conatus Pharmaceuticals' Stock Surged 23%

By: via Benzinga
Shares of Conatus Pharmaceuticals Inc (NASDAQ: CNAT), a nano-cap biotechnology company focused on the development and ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.